Regenxbio (RGNX) Return on Assets (2016 - 2025)
Regenxbio (RGNX) has 11 years of Return on Assets data on record, last reported at 0.4% in Q4 2025.
- For Q4 2025, Return on Assets rose 6.0% year-over-year to 0.4%; the TTM value through Dec 2025 reached 0.4%, up 6.0%, while the annual FY2025 figure was 0.42%, 42.0% down from the prior year.
- Return on Assets reached 0.4% in Q4 2025 per RGNX's latest filing, down from 0.32% in the prior quarter.
- Across five years, Return on Assets topped out at 0.13% in Q4 2021 and bottomed at 0.46% in Q4 2024.
- Average Return on Assets over 5 years is 0.26%, with a median of 0.33% recorded in 2025.
- Peak YoY movement for Return on Assets: soared 34bps in 2022, then tumbled -48bps in 2023.
- A 5-year view of Return on Assets shows it stood at 0.13% in 2021, then tumbled by -344bps to 0.33% in 2022, then tumbled by -34bps to 0.44% in 2023, then decreased by -6bps to 0.46% in 2024, then rose by 14bps to 0.4% in 2025.
- Per Business Quant database, its latest 3 readings for Return on Assets were 0.4% in Q4 2025, 0.32% in Q3 2025, and 0.33% in Q2 2025.